The offering of pseudotherapies in neurodevelopmental disorders is broad and not without consequences regarding financial cost, opportunity cost, and ethical implications, so professionals must remain informed and recommend evidence-based treatments.
The Association to Protect Patients from Pseudoscientific Therapies offers a list of the main pseudotherapies.
Institutional initiatives have also been developed to raise awareness among the general population, such as the website ConPrueba of the Ministry of Science, or the observatory against pseudosciences, pseudotherapies, professional intrusion, and health sects of the OMC.